What Is Kazia Therapeutics Limited (KZIA) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Kazia Therapeutics Limited's intrinsic value is estimated at $5.41, suggesting the stock is overvalued at its current price of $13.44. With 9 out of 10 models flagging downside (-59.8% average return), the market may be pricing in unsustainable growth. The most optimistic model, PWERM, places fair value at $13.68 (+1.8%), while ML-RIV — the most conservative — estimates $0.43 (-96.8%). This +98.6% gap reflects genuine analytical uncertainty about Kazia Therapeutics Limited's intrinsic worth.
What Do the Models Say About KZIA?
10 of 13 models are currently active for KZIA. Of these, 1 model suggests upside while 9 models suggest overvaluation. The Bayesian DCF estimates KZIA's intrinsic value at $4.49, implying -66.6% downside from the current price. See which stocks rank higher →
How Does KZIA Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, KZIA ranks #181 by Quality of Company score. CirclFi's QOC score of 5.2/10 evaluates 32 fundamental signals. A score of 5.2 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a pharmaceutical industry, Kazia Therapeutics Limited operates in a sector where patent cliff exposure is a critical driver of valuation. Investors evaluating KZIA should weigh these sector-specific dynamics alongside our model-derived fair values.
Is KZIA a Value Trap?
CirclFi's Value Trap algorithm assigns KZIA a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
10 of 13 models are active for Kazia Therapeutics Limited. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Kazia Therapeutics Limited's fundamental quality profile registers 5.2/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +98.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every KZIA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across KZIA's 10 active models, average confidence is 26%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad